LATESTSEARCH ⌕
NASDAQ / LIVE COMPANY INTELLIGENCE

Taysha Gene Therapies, Inc.

Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.

TICKERTSHA
CORENasdaq-listed company
WATCHEarnings + filings + operating news
STATUSContinuously updated
LIVE / TSHA COVERAGE

What’s moving Taysha Gene Therapies, Inc. now

Current reporting with the operating signal separated from the noise.

01
Traders Union

Catalent to supply TSHA-102 under new commercial agreement with Taysha Gene Therapies, Inc.

The story matters when it changes Taysha Gene Therapies, Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
PRIMARY DOCUMENTS / SEC EDGAR

Latest TSHA filings.

Investor-relevant reports are shown first, followed by the company’s other recent official submissions.

10-QQuarterly financial reportFiled 2026-05-06 · Period 2026-03-31SEC ↗10-QQuarterly financial reportFiled 2025-11-04 · Period 2025-09-30SEC ↗10-KAnnual financial reportFiled 2026-03-19 · Period 2025-12-31SEC ↗8-KMaterial company eventFiled 2026-06-25 · Period 2026-06-24SEC ↗8-KMaterial company eventFiled 2026-06-22 · Period 2026-06-22SEC ↗8-KMaterial company eventFiled 2026-06-02 · Period 2026-06-01SEC ↗DEF 14AProxy and shareholder meetingFiled 2026-04-22 · Period 2026-06-01SEC ↗144Official SEC filingFiled 2026-07-10SEC ↗
EARNINGS / QUARTERLY TRACKER

Taysha Gene Therapies, Inc., quarter by quarter.

Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.